Back
IGC Pharma Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
39
IGC
IGC Pharma
Last Price:
$0.36
Seasonality Move:
49.57%
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
$14.08
Seasonality Move:
29.39%
Sell
39
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
-
The current IGC Pharma [IGC] share price is $0.36. The Score for IGC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $14.08. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $14.08The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
IGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 58.19 | Buy |
Chaikin Money Flow: | 1203832 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.29 - 0.35) | Buy |
Bollinger Bands (100): | (0.29 - 0.33) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.01 | Buy |
Relative Strength Index (14 RSI): | 30.81 | Sell |
Chaikin Money Flow: | -47284273 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.93 - 25.27) | Sell |
Bollinger Bands (100): | (23.99 - 79.25) | Sell |
IGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.36 | Sell |
20-day SMA: | 0.33 | Buy |
50-day SMA: | 0.32 | Buy |
200-day SMA: | 0.33 | Buy |
8-day EMA: | 0.32 | Buy |
20-day EMA: | 0.21 | Buy |
50-day EMA: | 0.11 | Buy |
200-day EMA: | 0.03 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.56 | Sell |
20-day SMA: | 18.29 | Sell |
50-day SMA: | 29.07 | Sell |
200-day SMA: | 86.06 | Sell |
8-day EMA: | 16.26 | Sell |
20-day EMA: | 10.95 | Buy |
50-day EMA: | 5.61 | Buy |
200-day EMA: | 1.6 | Buy |
IGC Pharma Earnings Growth & IGC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.12 per share, and a decrease next year of $0.01 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $1.02 per share, a decrease this year of $6.30 per share, and an increase next year of $6.46 per share.
IGC Pharma Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |